Elsevier

Atherosclerosis

Volume 101, Issue 2, July 1993, Pages 185-190
Atherosclerosis

Stimulation of endothelin-1 release by low density and very low density lipoproteins in cultured human endothelial cells

https://doi.org/10.1016/0021-9150(93)90115-BGet rights and content

Abstract

To examine the effects of lipoproteins on the secretion of endothelin-1 from endothelial cells, we measured immunoreactive (ir) endothelin-1 release from cultured human umbilical vein endothelial cells in the presence or absence of various concentrations of native low density lipoprotein (LDL), oxidized LDL, and very low density lipoprotein (VLDL). Cultured endothelial cells secreted ir-endothelin-1 into serum-free medium in a time-dependent manner, and the secretion was clearly stimulated following a 15–24-h incubation with 10 μg/ml oxidized LDL. The secretion of ir-endothelin-1 increased in a dose-dependent manner after a 24-h incubation with oxidized LDL, while only a high dose of native LDL and VLDL significantly increased ir-endothelin-1 secretion. The release of ir-endothelin-1 stimulated by 20 μg/ml oxidized LDL was reproduced by the same concentration of acetylated LDL but not native LDL. These observations indicate that the release of ir-endothelin-1 from endothelial cells is stimulated by lipoproteins, in particular by oxidized LDL, probably through the endothelial scavenger receptor. This increase in iendothelin-1 release induced by oxidized LDL may contribute to the development of atherosclerotic vascular lesions.

References (34)

  • D. Steinberg et al.

    Modifications of low-density lipoprotein that increase its atherogenicity

    N. Engl. J. Med.

    (1989)
  • T.E. Carew

    Role of biologically modified low-density lipoprotein in atherosclerosis

    Am. J. Cardiol.

    (1989)
  • R. Ross et al.

    The pathogenesis of atherosclerosis

    N. Engl. J. Med.

    (1976)
  • R. Ross

    The pathogenesis of atherosclerosis: an update

    N. Engl. J. Med.

    (1986)
  • S.M. Schwartz et al.

    Developmental mechanisms underlying pathology of arteries

    Physiol. Rev.

    (1990)
  • M. Yanagisawa et al.

    A novel potent vasoconstrictor peptide produced by vascular endothelial cells

    Nature

    (1988)
  • A. Lerman et al.

    Circulating and tissue endothelin immunoreactivity in advanced atherosclerosis

    N. Engl. J. Med.

    (1991)
  • Cited by (0)

    View full text